These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31080533)

  • 1. Will I lose my license for that? A closer look at Canadian disciplinary hearings and what it means for pharmacists' practice to full scope.
    Foong EA; Grindrod KA; Houle SKD
    Can Pharm J (Ott); 2018; 151(5):332-344. PubMed ID: 31080533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist Disciplinary Action: What Do Pharmacists Get in Trouble for?
    Foong-Reichert AL; Grindrod KA; Edwards DJ; Austin Z; Houle SKD
    Healthc Policy; 2023 Feb; 18(3):60-71. PubMed ID: 36917454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dentist Disciplinary Action: What Do Dentists Get in Trouble for?
    Foong-Reichert AL; Houle SKD; Austin Z; Edwards DJ; Grindrod KA
    Healthc Policy; 2023 Feb; 18(3):72-83. PubMed ID: 36917455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in pharmacists' disciplinary processes and outcomes.
    Hattingh L; Smith N; Searle J; Forrester K
    J Law Med; 2008 Aug; 16(1):109-19. PubMed ID: 18807799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wrong drug and wrong dose dispensing errors identified in pharmacist professional liability claims.
    Reiner G; Pierce SL; Flynn J
    J Am Pharm Assoc (2003); 2020; 60(5):e50-e56. PubMed ID: 32217085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insurance for the compounding pharmacy business, part 2: what, when, and where.
    Baker KR
    Int J Pharm Compd; 2008; 12(6):514-23. PubMed ID: 23969929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pharmacy practice on community pharmacists' integration of medication and lab value information from electronic health records.
    Hughes CA; Guirguis LM; Wong T; Ng K; Ing L; Fisher K
    J Am Pharm Assoc (2003); 2011; 51(5):591-8. PubMed ID: 21896456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacy teams' experiences of general practice-based pharmacists: an exploratory qualitative study.
    Karampatakis GD; Patel N; Stretch G; Ryan K
    BMC Health Serv Res; 2020 May; 20(1):431. PubMed ID: 32423485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurance for the Compounding Business, Part 1: Who is Covered?
    Baker KR
    Int J Pharm Compd; 2008; 12(5):420-4. PubMed ID: 23969866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' Scope of Practice: Supports for Canadians with Diabetes.
    Mansell K; Edmunds K; Guirguis L
    Can J Diabetes; 2017 Dec; 41(6):558-562. PubMed ID: 29037573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and risk factors of pharmacist misconduct in New Zealand: a retrospective nationwide analysis.
    Wang Y; Ram SS; Scahill S
    BMC Health Serv Res; 2024 Feb; 24(1):223. PubMed ID: 38378632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: A systematic review.
    El Hajj MS; Mekkawi R; Elkaffash R; Saleh R; El Awaisi A; Wilbur K
    Res Social Adm Pharm; 2021 Aug; 17(8):1373-1395. PubMed ID: 33257161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services.
    Rosenthal M; Tsao NW; Tsuyuki RT; Marra CA
    Res Social Adm Pharm; 2016; 12(1):56-67. PubMed ID: 26050916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of patients' requests and pharmacists' professional practice in oropharyngeal condition in Spain.
    Hernández A; Garcia-Delgado P; Garcia-Cardenas V; Ocaña A; Labrador E; Orera ML; Martinez-Martinez F
    Int J Clin Pharm; 2015 Apr; 37(2):300-9. PubMed ID: 25708123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expunging Board of Pharmacy Disciplinary Actions.
    Adams AJ; Frost TP
    Innov Pharm; 2023; 14(1):. PubMed ID: 38035318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.
    Bailey AM; Wermeling DP
    Ann Pharmacother; 2014 May; 48(5):601-6. PubMed ID: 24523396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do community pharmacist performance evaluations capture the modern pharmacist's role? Mapping competencies assessed in Canadian community pharmacy performance evaluation templates against the General Level Framework.
    Chong IYM; Rosenthal MM; Manson KR; Houle SKD
    J Am Pharm Assoc (2003); 2018; 58(6):638-642.e2. PubMed ID: 30237009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics of physicians disciplined by professional colleges in Canada.
    Alam A; Klemensberg J; Griesman J; Bell CM
    Open Med; 2011; 5(4):e166-72. PubMed ID: 22567070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.